GSK’s Acquisition of Efimosfermin

Cleary Gottlieb Steen & Hamilton represented GSK, while Sullivan & Cromwell represented Boston Pharmaceuticals in the transaction.GSK announced its acquisition of Boston Pharmaceuticals’ lead asset efimosfermin…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here